Peer-reviewedCC BY-NC-SAIndian journal of urology : IJU : journal of the Urological Society of India
Perioperative apalutamide in high-risk localized or locally advanced prostate cancer: Is PROTEUS trial practice changing?
- 1Department of Urology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Related
- Skin‐Related Adverse Events in Patients Treated With Apalutamide Versus Enzalutamide for Prostate Cancer: A Japanese Real‐World Database Study (A Retrospective Cohort Study)
- Apalutamide-Induced Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome in a Patient With Metastatic Prostate Cancer: A Case Report
- Real-World Early Prostate-Specific Antigen Response Comparison Among Patients with Metastatic Castration Sensitive Prostate Cancer Treated with Apalutamide or Abiraterone Acetate in the United States.
- Neoadjuvant Apalutamide With or Without Abiraterone Acetate Plus Prednisone and Gonadotropin-Releasing Hormone Agonist Prior to Nerve-Sparing Radical Prostatectomy in High-Risk Prostate Cancer: Protocol for a Randomized Phase 2 Trial
- Feasibility and early outcomes of salvage robot-assisted radical prostatectomy after focal therapy failure for localized prostate cancer
BibTeX
@article{huzaifa2026perioperative,
title = {{Perioperative apalutamide in high-risk localized or locally advanced prostate cancer: Is PROTEUS trial practice changing?}},
author = {Muhammed Huzaifa},
journal = {Indian journal of urology : IJU : journal of the Urological Society of India},
year = {2026},
month = sep,
doi = {10.4103/iju.iju_374_26},
url = {https://europepmc.org/article/MED/42910136},
note = {CC BY-NC-SA},
}
RIS
TY - JOUR
TI - Perioperative apalutamide in high-risk localized or locally advanced prostate cancer: Is PROTEUS trial practice changing?
AU - Muhammed Huzaifa
PY - 2026
DA - 2026/09/29
JO - Indian journal of urology : IJU : journal of the Urological Society of India
DO - 10.4103/iju.iju_374_26
UR - https://europepmc.org/article/MED/42910136
SN - 0970-1591
SN - 1998-3824
ER -